Audiomedica.com

Esophageal Cancer Prevented By Proton Pump Inhibitor Plus Aspirin

Informações:

Sinopsis

CHICAGO—A 25 per cent risk reduction for esophageal cancer was found to be associated with prophylactic therapy consisting of a proton pump inhibitor (PPI) and aspirin in the phase three randomized ASPECT multicenter study from the United Kingdom reported at …Jaanusz Jankowski AJO PRODUCTION MASTER 8'54